NUP43 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.180800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.010000E-01
Normal-vs-Stage2
4.239600E-01
Normal-vs-Stage3
1.985830E-01
Normal-vs-Stage4
4.524400E-01
Stage1-vs-Stage2
9.546200E-01
Stage1-vs-Stage3
1.457970E-01
Stage1-vs-Stage4
7.061200E-01
Stage2-vs-Stage3
3.461900E-02
Stage2-vs-Stage4
6.092600E-01
Stage3-vs-Stage4
3.447900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.266000E-01
Normal-vs-AfricanAmerican
4.480200E-01
Normal-vs-Asian
5.490400E-02
Caucasian-vs-AfricanAmerican
9.050600E-01
Caucasian-vs-Asian
1.578640E-01
AfricanAmerican-vs-Asian
2.288800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.204800E-01
Normal-vs-Female
6.668200E-02
Male-vs-Female
9.319000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.442200E-01
Normal-vs-Age(41-60Yrs)
4.866000E-01
Normal-vs-Age(61-80Yrs)
3.846800E-01
Normal-vs-Age(81-100Yrs)
1.742030E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.605200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.351200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.598200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.865600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.660400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.870000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.833600E-02
Normal-vs-Daily Drinker
3.181800E-01
Normal-vs-Weekly Drinker
2.817800E-01
Normal-vs-Occasional Drinker
4.657800E-01
Normal-vs-Social Drinker
1.707400E-01
Non Drinker-vs-Daily Drinker
2.018000E-01
Non Drinker-vs-Weekly Drinker
5.971200E-01
Non Drinker-vs-Occasional Drinker
6.427600E-01
Non Drinker-vs-Social Drinker
6.557800E-01
Daily Drinker-vs-Weekly Drinker
1.320950E-01
Daily Drinker-vs-Occasional Drinker
7.511500E-02
Daily Drinker-vs-Social Drinker
1.095980E-01
Weekly Drinker-vs-Occasional Drinker
8.703000E-01
Weekly Drinker-vs-Social Drinker
9.065600E-01
Occasional Drinker-vs-Social Drinker
9.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.745600E-01
Normal-vs-Grade 2
9.727800E-01
Normal-vs-Grade 3
9.272400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.800600E-01
Grade 1-vs-Grade 3
1.612590E-01
Grade 1-vs-Grade 4
9.745600E-01
Grade 2-vs-Grade 3
3.332000E-02
Grade 2-vs-Grade 4
9.727800E-01
Grade 3-vs-Grade 4
9.272400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.678200E-01
Normal-vs-NonDiabetic
4.070600E-01
Diabetic-vs-NonDiabetic
4.253800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.263400E-01
Normal-vs-NoPancreatitis
3.915600E-01
Pancreatitis-vs-NoPancreatitis
7.353800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.179700E-02
Normal-vs-N1
4.246200E-01
N0-vs-N1
9.486600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.181200E-01
Normal-vs-TP53-NonMutant
5.423800E-01
TP53-Mutant-vs-TP53-NonMutant
7.671400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
